SABCS 2021 Conference Coverage on VuMedi


 

SABCS 2021 Update on T-DXd in Patients With HER2+ or HER2-Low-Expressing Advanced Breast Cancer and CNS Involvement: Preliminary Results From the DEBBRAH Phase 2 Study

325 views
December 13, 2021
Comments 0
Login to view comments. Click here to Login